Enochian BioSciences, Inc. (ENOB)
Levi & Korsinsky, LLP announces that a ENOB class action lawsuit has been filed on behalf of investors who purchased Enochian BioSciences, Inc. (ENOB) securities between January 17, 2018 and June 27, 2022. For more on the ENOB Lawsuit please contact us today.
According to the Enochian BioSciences, Inc. lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:
(1) the Company’s co-founder and inventor Serhat Gumrukcu was engaged in a variety of frauds; (2) Gumrukcu was not a licensed doctor anywhere in the world; (4) as a result of the foregoing, Gumrukcu’s purported contributions to the Company lacked a reasonable basis; (5) as a result of the foregoing, the Company had overstated its commercial prospects; (6) Gumrukcu had improperly diverted approximately $20 million from Enochian to entities he owned; and (7) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
If you suffered a loss in Enochian BioSciences, Inc. you have until September 26, 2022 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Enochian BioSciences, Inc. Class Action Lawsuit
Enochian BioSciences, Inc. Lawsuit
ENOB Class Action Lawsuit
Enochian BioSciences, Inc. (ENOB) Class Action Lawsuit